GILD241206P45000
- 0.00
- 0.000.00%
Gilead Sciences Newsroom
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Gilead Sciences Ticks Upward for the Eight Consecutive Session
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December Starts With a Mixed Market | Live Stock
Benign Growth For Gilead Sciences, Inc. (NASDAQ:GILD) Underpins Its Share Price
Express News | Gilead : Jefferies Raises Target Price to $115 From $105
Insider Sale: Chief Medical Officer of $GILD (GILD) Sells 3,199 Shares
Gilead Sciences(GILD.US) Officer Sells US$15.09 Million in Common Stock
Express News | Form 144 | Gilead Sciences(GILD.US) Officer Proposes to Sell 23.07 Million in Common Stocks
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here Is What You Need to Know
RBC Capital Sticks to Their Hold Rating for Gilead Sciences (GILD)
Gilead Announces New England Journal of Medicine Publication of PURPOSE 2 Results
Express News | Gilead Announces New England Journal of Medicine Publication of Purpose 2 Results
Express News | Form 144 | Gilead Sciences(GILD.US) Officer Proposes to Sell 15.09 Million in Common Stocks
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Gilead Acquires Investigational HIV Vaccine From Spanish Biotech Aelix